BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1382 related articles for article (PubMed ID: 1729780)

  • 1. Risk factors for breast cancer in women undergoing mammography.
    Reuter KL; Baker SP; Krolikowski FJ
    AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics that predict risk of breast cancer before and after the menopause.
    Paffenbarger RS; Kampert JB; Chang HG
    Am J Epidemiol; 1980 Aug; 112(2):258-68. PubMed ID: 7416152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and 10-year breast cancer survival in northern Alberta.
    Lees AW; Jenkins HJ; May CL; Cherian G; Lam EW; Hanson J
    Breast Cancer Res Treat; 1989 Mar; 13(2):143-51. PubMed ID: 2730961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of cholelithiasis during pregnancy and its relationship with age, parity, menarche, breast-feeding, dysmenorrhea, oral contraception and a maternal history of cholelithiasis.
    Basso L; McCollum PT; Darling MR; Tocchi A; Tanner WA
    Surg Gynecol Obstet; 1992 Jul; 175(1):41-6. PubMed ID: 1621198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for pathologically confirmed benign breast disease.
    Parazzini F; La Vecchia C; Franceschi S; Decarli A; Gallus G; Regallo M; Liberati A; Tognoni G
    Am J Epidemiol; 1984 Jul; 120(1):115-22. PubMed ID: 6741913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and breast cancer risk in Taiwan, a country of low incidence of breast cancer and low use of oral contraceptives.
    Chie WC; Li CY; Huang CS; Chang KJ; Yen ML; Lin RS
    Int J Cancer; 1998 Jul; 77(2):219-23. PubMed ID: 9650556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk.
    Kampert JB; Whittemore AS; Paffenbarger RS
    Am J Epidemiol; 1988 Nov; 128(5):962-79. PubMed ID: 3189296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer in premenopausal and postmenopausal women.
    Stavraky K; Emmons S
    J Natl Cancer Inst; 1974 Sep; 53(3):647-54. PubMed ID: 4412246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of reproductive factors and use of oral contraceptives in the aetiology of breast cancer in women aged 50 to 74 years.
    Magnusson CM; Persson IR; Baron JA; Ekbom A; Bergström R; Adami HO
    Int J Cancer; 1999 Jan; 80(2):231-6. PubMed ID: 9935204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron status markers, serum ferritin and hemoglobin in 1359 Danish women in relation to menstruation, hormonal contraception, parity, and postmenopausal hormone treatment.
    Milman N; Kirchhoff M; Jørgensen T
    Ann Hematol; 1992 Aug; 65(2):96-102. PubMed ID: 1511065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraception, parity, breast feeding, and severity of rheumatoid arthritis.
    Jorgensen C; Picot MC; Bologna C; Sany J
    Ann Rheum Dis; 1996 Feb; 55(2):94-8. PubMed ID: 8712873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and premenopausal breast cancer in nulliparous women.
    Stadel BV; Lai SH; Schlesselman JJ; Murray P
    Contraception; 1988 Sep; 38(3):287-99. PubMed ID: 3168449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of height, weight, menstrual and reproductive events with breast cancer: results from two prospective studies on the island of Guernsey (United Kingdom).
    De Stavola BL; Wang DY; Allen DS; Giaconi J; Fentiman IS; Reed MJ; Bulbrook RD; Hayward JL
    Cancer Causes Control; 1993 Jul; 4(4):331-40. PubMed ID: 8347782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Events of reproductive life and the incidence of epithelial ovarian cancer.
    Risch HA; Weiss NS; Lyon JL; Daling JR; Liff JM
    Am J Epidemiol; 1983 Feb; 117(2):128-39. PubMed ID: 6681935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
    Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
    JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Can breast cancer be prevented?].
    Vatten LJ
    Tidsskr Nor Laegeforen; 1991 May; 111(14):1745-8. PubMed ID: 2063386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproductive and hormonal factors and breast cancer in a Northern Italian population.
    Talamini R; La Vecchia C; Franceschi S; Colombo F; Decarli A; Grattoni E; Grigoletto E; Tognoni G
    Int J Epidemiol; 1985 Mar; 14(1):70-4. PubMed ID: 3988443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women.
    Plu-Bureau G; Thalabard JC; Sitruk-Ware R; Asselain B; Mauvais-Jarvis P
    Br J Cancer; 1992 Jun; 65(6):945-9. PubMed ID: 1616869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.